In triple knock-out (TKO) mice with silenced Tp53fl/fl, Rb1fl/fl, and Rb2fl/fl, SCLC tumors evolved within four to six months and acquired NE characteristics accompanied by predominant ASCL1 expression. This evidence concerns the gene ASCL1 and small cell lung carcinoma.